ABHILASHA MAHESH SINGH
Allopathic & Osteopathic Physicians|Internal Medicine BOWLING GREEN, KY NPI 1821081779
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine KY Amgen Inc. All categories
General Payments — all program years on this page
$1,686.69
- Category: General Payments
- Program years: PY2018–2024
- Record count: 68
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $226.74 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $226.74 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $142.17 | 3 |
| Ultragenyx Pharmaceutical Inc. | $22.48 | 1 |
| Mylan Specialty L.P. | $18.73 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.49 | 1 |
| Esperion Therapeutics, Inc. | $14.44 | 1 |
| Novo Nordisk AS | $13.43 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086269376 | Bayer Healthcare Pharmaceuticals Inc. | $15.49 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096683751 | Novo Nordisk Inc | $13.43 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117384133 | Amgen Inc. | $6.72 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117384135 | Amgen Inc. | $21.48 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117384137 | Amgen Inc. | $113.97 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1129455596 | Esperion Therapeutics, Inc. | $14.44 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147341370 | Mylan Specialty L.P. | $18.73 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153282765 | Ultragenyx Pharmaceutical Inc. | $22.48 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.